Private insurers are improperly rejecting Medicare drug claims, watchdog finds

The private insurers operating Medicare Part D drug plans may be putting profits ahead of patient interests, according to a report from the program’s watchdog. The report, issued by the U.S Department of Health and Human Services’ Office of Inspector General, analyzed rejections of millions of prescription requests during 2017, the most recent year for which comprehensive information is available.